Key result
Cardiac troponin I assessed at 72 hours from symptom onset accurately estimated predischarge infarct volume, outperforming creatine kinase-myocardial band.
Why the study?
Does cardiac troponin I (cTnI) measurement at 72 hours from symptom onset improve the estimation of predischarge infarct volume compared to CK-MB in patients with a first acute myocardial infarction?
Observational (n=60)
Does cardiac troponin I (cTnI) measurement at 72 hours from symptom onset improve the estimation of predischarge infarct volume compared to CK-MB in patients with a first acute myocardial infarction?
A single cTnI measurement at 72 hours post-symptom onset accurately estimates infarct size in patients with a first acute myocardial infarction, outperforming CK-MB and peak cTnI values.
Answers are grounded in this paper and cite their sources.
May support 72-hour cTnI for post-MI infarct sizing; hypothesis-generating and should not yet change practice.
BACKGROUND: The estimation of infarct size by biochemical myocardial necrosis markers is used in current clinical practice, rather than the more expensive and not always available imaging techniques. However, for this purpose, the peak value of serum biomarkers can overestimate the necrotic area, especially after reperfusion. OBJECTIVE: We investigated whether late release cardiac troponin I (cTnI) values could predict more precisely infarct volume measured by delayed-enhancement cardiac magnetic resonance (DE-CMR) in patients with acute myocardial infarction [ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI)] independently of reperfusion (spontaneous and provoked). METHODS: Sixty patients with a first acute myocardial infarction (55 STEMI and five NSTEMI) and normal function were enrolled. Among STEMI patients, 52 underwent reperfusion. cTnI and creatine kinase-myocardial band were assessed at admission and at 6, 12, 24, 48, 72 and 96 h (+/-1 h) from symptom onset. DE-CMR (Siemens Avanto 1.5T) was performed before discharge (4 +/- 2 days). Infarct size was determined by manual delineation of the areas of delayed enhancement. Infarct volume was calculated as the sum of each slice of infarct size area multiplied by thickness. RESULTS: Peak cTnI was 55 +/- 59 ng/ml (range 0.3-347). The area under the curve of cTnI was 1916 +/- 2224 ng/ml. The volume of infarcted myocardium assessed by DE-CMR was 27 +/- 25 ml (range 0-134). The single value of cTnI at 72 h after symptom onset provided the most accurate estimation of predischarge infarct volume (r = 0.84, 95% confidence interval 0.75-0.91) and was significantly more accurate than creatine kinase-myocardial band value assessed at any time during the same period (r = 0.42, 95% confidence interval 0.19-0.62; P < 0.002). CONCLUSION: In patients with a first acute myocardial infarction, cTnI value assessed at 72 h from symptom onset shows the best correlation with predischarge infarct volume as assessed by DE-CMR and is superior to cTnI and creatine kinase-myocardial band peak and total values.
No takes yet. Share an insight, caveat, or question.
Chiara et al. (2010) conducted an observational in Acute myocardial infarction (STEMI and NSTEMI) (n=60). Cardiac troponin I (cTnI) assessment at 72 hours vs. Creatine kinase-myocardial band (CK-MB) assessment was evaluated on Predischarge infarct volume as assessed by DE-CMR (r = 0.84, 95% CI 0.75-0.91, p=< 0.002). Cardiac troponin I assessed at 72 hours from symptom onset accurately estimated predischarge infarct volume, outperforming creatine kinase-myocardial band.
Synapse has enriched 10 related papers. Consider them for comparative context: